ABBREVIATIONS CCA = cavernous carotid artery; CN = cranial nerve; CS = cavernous sinus; GTR = gross-total resection; ICA = internal carotid artery; KS = KnospSteiner. OBJECTIVE Surgery within the cavernous sinus (CS) remains a controversial topic because of the delicate and complex anatomy. The risk also varies with tumor consistency. Softer tumors such as pituitary adenomas are more likely to be surgically treated, while firm tumors such as meningiomas are often treated with radiosurgery. However, a wide range of pathologies that can involve the CS are amenable to surgery. The authors describe and analyze their results using endonasal endoscopic "medial-to-lateral" approaches for nonadenomatous, nonmeningeal tumors, in relation to the degree of invasion within the CS. METHODS A prospectively acquired database of consecutive endoscopic approaches for tumors with verified intraoperative CS invasion was reviewed. Pituitary adenomas and meningiomas were excluded. Degree of invasion of the CS was classified using the Knosp-Steiner (KS) grading system as well as the percentage of cavernous carotid artery (CCA) encasement. Extent of resection of the entire tumor and of the CS component was assessed by independent neuroradiologists using volumetric measurements of the pre-and postoperative MRI studies. Demographic data and complications were noted. RESULTS Fifteen patients (mean age 51.1 years who received endoscopic surgery between 2007 and 2013 met the selection criteria. There were 11 malignant tumors, including chordoma, chondrosarcoma, hemangiopericytoma, lymphoma, and metastatic cancer, and 4 benign tumors, including 3 cavernous hemangiomas and 1 dermoid. All cases were discussed before treatment in a tumor board. Adjuvant treatment options included chemotherapy and radiotherapy. The mean pre-and postoperative tumor volumes were 12.74 ml and 3.86 ml. Gross-total resection (GTR; ie, resection greater than 95%) was the goal in 13 cases and was achieved in 6 patients (46%) while in addition 5 patients had a greater than 80% resection. Gross-total resection in the CS was accomplished in 55% of the tumors with KS Grades 1-2 and in 16.6% of the tumors with KS grades 3-4, respectively. Likewise, GTR was accomplished in 55% of the tumors with CCA encasement under 75% and in 14.3% of the lesions with CCA encasement over 75%, irrespective of tumor volume and underlying pathology. There were 18 preexisting cranial neuropathies involving cranial nerves III-VI, of which 9 fully resolved, 4 improved, and 3 remained unchanged; 2 of these worsened with tumor recurrence. Surgical complications included 1 transient new cranial nerve VI palsy associated with Horner's syndrome and 1 case of panhypopituitarism. There were no postoperative CSF leaks and no infections. The mean extended follow-up was 34.4 months. CONCLUSIONS Endonasal endoscopic approaches can play a role in the management of nonmeningeal, nonadenomatous tumors invading the CS, either through biopsy, debulking, or GTR. An advantage of this method is the relief of preexisting cranial neuropathies with low risk for new neurological deficit. Extent of resection within the CS varies with KS grade and degree of carotid encasement irrespective of the underlying pathology. The goals of surgery should be clearly established preoperatively in consultation with radiation and medical oncologists.
T he parasellar compartment referred to as the cavernous sinus (CS) is an extradural space between the 2 layers of the dura mater, laterally and superiorly, and the periosteum of the sphenoid bone, medially and inferiorly. It contains fat, arteries (the cavernous segment of the carotid artery with its meningohypophyseal branches), nerves (the sixth cranial nerve [CN] and sympathetic nerves), and a plexus of veins. The third and fourth cranial nerves and the first division of the fifth CN are enclosed in the inner dural layer of the lateral wall. 34, 53, 55, 71 The pioneering anatomical work of Taptas and the surgical explorations by Parkinson, Dolenc, and others formed the modern understanding of this complex anatomy and paved the way for surgery in this region via transcranial routes. 1, 13, 16, 17, 37, 42, 51, 54, [60] [61] [62] 70 Neoplasms involving the CS are, however, diverse, and the traditional transcranial routes achieve best results with selected tumors, especially interdural tumors of the lateral sinus wall. For invasive tumors without a well-defined cleavage plane between the tumor and the parasellar neurovascular structures, the results are less favorable. 13, 37, 38 Brain retraction and manipulation of neurovascular structures draped over the tumor during transcranial approaches are associated with a significant risk for neurological morbidity. 13, 22, 37, 38, 42, 50, 63, 64 In more recent years, extended endonasal endoscopic techniques have made possible an alternative medialto-lateral approach to the CS, offering the advantage of placing the cranial nerves on the far side of the approach. 2, 7, 15, 23, 32, 38 Clinical reports on endonasal CS surgery have mostly concerned removal of soft pituitary tumors or biopsies of various other lesions. 8, 10, 21, 23, 29, 33, 45, 49, 56, 57, 68, 77 In this study we expand on prior reports by analyzing a series of endonasal endoscopic surgeries for nonpituitary, nonmeningioma tumors with significant extension within the CS, focusing on the feasible extent of resection and neurological outcome in association with Knosp-Steiner (KS) grade and degree of cavernous carotid artery (CCA) encasement.
Methods
Weill Cornell Medical College institutional review board approval was obtained. We reviewed a prospectively acquired database of all endoscopic endonasal surgeries performed between 2007 and 2013 by two surgeons (T.H.S. and V.K.A.) at the NewYork Presbyterian Hospital to identify nonmeningioma, nonpituitary lesions involving the CS based on the results of histopathological examinations. Cases were only included if the CS invasion was visualized and verified during surgery and if the purpose of surgery was to remove or biopsy tumor in this region. All patients were studied with preoperative contrast-enhanced MRI. Postoperative Gd-enhanced MRI studies were obtained for all tumors on postoperative Day 1 and at 3 months after surgery and then at yearly intervals. All pre-and postoperative imaging was retrospectively reviewed by 2 independent neuroradiologists (A.J.T. and A.M.) who calculated the total tumor volumes pre-and postoperatively and also the extent of resection within the CS using volumetric measurements. The extent of resection was evaluated on MRI studies obtained on postoperative Day 1. The volumetric measurements were performed on a GE Advantage Workstation using Volume Analysis 3Doption according to Cavalieri's principle in which the total volume is the product of the distance between slices (T) and the sum of the areas on the cut surfaces on each section: [total tumor volume = T × S (A1−m) where T is the distance between sections, A is the area of the cut surface, and S (A1−m) is the sum of reference areas on the face of sections 1 to m]. The degree of CS invasion was classified according to the criteria proposed by Knosp et al. (KS Classification) , 36 and the percentage of the CCA encasement, calculated as proposed by Cottier et al. 12 The criteria for the KS Classification are shown in Fig. 1 , and calculation of the CCA encasement is demonstrated in Fig. 2 .
Endoscopic endonasal surgery via the transsphenoidal transsellar route and extended approaches (suprasellar and lateral and/or transclival) was performed in a standard fashion as described in previous publications; 47, 57, 60, 77 however, a brief description follows. After induction of general anesthesia, a lumbar puncture was performed, and 0.2 ml of 10% fluorescein was injected in 10 ml of CSF to help visualize CSF leaks. If a large CSF leak was expected, a lumbar drain for prophylactic drainage (rate of no more than 5 ml/hour) was placed. Briefly, the patient's head was placed in 3-point fixation and registered using MRI-based neuronavigation. The nasal mucosa was topically exposed to cottonoids soaked in 4 ml of 4% cocaine and the mucosa of the middle turbinates was injected with a mixture of lidocaine 1% and epinephrine (1:100,000). The middle and superior turbinates were retracted laterally, and the sphenoid ostia were identified bilaterally. A nasoseptal flap was harvested by making cuts in the septal mucosa 1 mm above the palate and 2-3 mm below the cribriform plate until they met anteriorly. The mucosa was elevated off the septum with care taken to preserve the vascular supply from the sphenopalatine artery. The flap was dissected off the face of the sphenoid sinus and retracted into the choana where it was stored until the end of the operation. The posterior one-third of the nasal septum adjacent to the vomer and maxillary crest was resected with a tissue shaver. This approach can be extended superiorly by removal of the tuberculum sellae and inferiorly by removal of the upper clivus.
For the extended transtubercular, transplanar approach, the posterior ethmoids were completely removed to visu- alize the tuberculum sellae and planum sphenoidale. A 0°, 30-cm rigid 4-mm endoscope (Karl Storz) was introduced through the left nostril and held in place with a flexible scope holder. The extent of removal of the tuberculum and planum were determined using image guidance to assure adequate exposure of the tumor and removal of the suprasellar component. This part of the procedure required a 30°, 30-cm, rigid 4-mm endoscope to achieve adequate upward visualization; then the bone over the CS was removed. This maneuver can be safely performed with a 1-mm Kerrison rongeur if the footplate is in the correct plane. The course of the carotid artery was identified with neuronavigation and a Doppler ultrasound. Through extensive previous experience a role has emerged for 3 distinct corridors in managing CS lesions. 60 Tumors of the medial CS were approached via the transsphenoidal transsellar approach, which is familiar from endoscopic pituitary surgery. An alternative was the transethmoidal transsphenoidal parasellar approach, which includes an anterior and posterior ethmoidectomy and resection of the superior turbinate for direct access to the anterior face of the CS through the lateral sphenoid sinus. Additional lateral exposure was gained by the transmaxillary transpterygoid approach, which requires the removal of the pterygoid process in addition to an ethmoidectomy, transethmoidal sphenoidotomy, and maxillary antrostomy. This approach can be used as a "far lateral" approach to tumors involving the lateral compartment of the CS.
Results
Review of the prospective surgical database of over 700 endonasal endoscopic cases identified 15 cases of nonmeningeal, nonpituitary tumors with extension into or origin within the CS verified with both radiographic evaluation and intraoperative visual inspection. The patient cohort consisted of 7 females and 8 males. The average age was 51.1 years (range 11-87 years). No patient had had previous surgery. The demographic data, preoperative symptoms, and histopathology are summarized in Table 1 .
Presenting symptoms included visual impairment, neuropathies of CN III-VI, and headache; headache was the only symptom in 2 patients. Most patients presented with a combination of symptoms. There were 18 neuropathies in 12 patients involving CN III-VI, most commonly CN VI (7 cases), followed by CN III (6 cases).
All cases were previously discussed in a tumor board consisting of neurosurgeons, medical oncologists, and radiotherapists, during which the goals of surgery were established. Biopsy was intended in 2 cases and resection greater than 95% in the other 13 cases. Histopathology revealed a lymphoma in the 2 biopsy cases, 3 cavernous hemangiomas, 2 metastatic cancers, 3 chordomas, 3 chondrosarcomas, 1 hemangiopericytoma, and 1 dermoid cyst. One tumor extended bilaterally; KS grade, CCA encasement, extent of resection, and cranial nerve palsies were noted for each side separately.
Tumor volumes and extent of resection according to KS grade, tumor histopathology, degree of CCA encasement, and surgical approach are summarized in Table 2 .
Based on the preoperative contrast-enhanced MRI findings, 1 lesion was KS Grade 1 and 8 were KS Grade 2. There were 2 tumors extending past the lateral aspect of the CCA (KS Grade 3) and 5 completely filling the CS (KS Grade 4).
Encasement of the CCA ranged from 17%-100%. We presumed a threshold value of 75% as significant. The mean tumor volume was 12.74 ml (range 4.32-35.80 ml). Contrast-enhanced MRI studies obtained on postoperative Day 1 revealed that gross-total resection (GTR) was achieved in 6 of the 13 cases in which it was attempted (46%). Greater than 80% resection was feasible in another 5 cases. Extent of resection within the CS was measured separately and GTR was accomplished in 55% of tumors with KS Grade 1-2 and in 16.6% of tumors with KS Grades 3-4, respectively.
Likewise, GTR in the CS was achieved in 55% of the tumors with CCA encasement < 75% and in 14.3% of lesions with CCA encasement > 75%. The achieved extent of resection within the CS does not seem to correlate with the tumor volume or the underlying pathology. A vascularized nasoseptal flap was used in 11 patients and a prophylactic lumbar drain in 5. Intraoperative CSF leaks were documented in 7 patients who had larger tumors than the rest of the patients (mean volume 19.28 ml vs 6.97 ml, respectively). The prophylactic lumbar drain was left in place for an average of 2.6 days. There were no postoperative leaks and no infections. Neurological outcomes were assessed from the electronic health records at discharge. The latest follow-up examinations took place during the patient's visit to the outpatient office.
Neurological outcomes at the last follow-up are listed in Table 3 .
Neuropathies of CN III-VI improved postoperatively in 7 patients (58.3%) and resolved completely in 3 (33.3%). Visual deficits improved in 1 patient and remained unchanged in the other 2. Altogether 11 of the 15 patients (73.3%) had significant relief of preexisting symptoms at discharge (Table 2) .
At the last follow-up 8 patients had complete recovery of the preexisting cranial neuropathies (overall rate 66.7%), 1 patient showed worsening with tumor recurrence, and 2 patients developed new cranial nerve palsies after radiation therapy and a second surgery, respectively. There were 2 perioperative complications, 1 permanent case of panhypopituitarism and 1 transient CN VI palsy associated with Horner's syndrome, which resolved 6 months after surgery.
The most recent outcomes and adjuvant therapies are summarized in Table 4 .
Adjuvant radiotherapy was given to 7 patients (to all patients with chordomas, 1 patient with chondrosarcoma, and also to the 2 patients with metastatic cancer and the patient with hemangiopericytoma). The patients with chordomas were treated with postoperative proton-beam radiotherapy, and the others received standard fractionated radiotherapy. Four of the 7 patients attained stable disease (57.14% with a mean follow up of 44.1 months). Tumor recurrence with progression was seen in 3 cases (2 chordomas and 1 chondrosarcoma) at a mean interval of 33.6 months. Both lymphoma patients were treated with chemotherapy with documented stable disease at the last follow-up (mean 9.4 months).
Discussion
At our institution, tumors that involve the CS have been addressed via a purely endoscopic endonasal approach since 2006. In our experience decompression of the CS via an endoscopic medial-to-lateral route is a safe, lowrisk procedure that can relieve preexisting cranial nerve deficits and rarely leads to new neuropathies. 43, 57, 60, 77 Although the most frequent tumors to invade the CS are adenomas and meningiomas, various other pathologies can be found in this location. Possibilities include cavernous hemangiomas, chordomas, chondrosarcomas, hemangiopericytomas, metastatic lesions, and also dermoid and epidermoid tumors, schwannomas, and juvenile angiofibromas. 13, 19, 20, 27, 28, 30, 33, 50, 58, 71, 72, 75, 80 Surgical planning requires knowledge of the CS anatomy and the tumor-specific characteristics such as origin and invasion patterns. In this paper we expand the indications for CS surgery to nonadenomatous, nonmeningeal pathologies. We have purposely left out meningiomas since radiosurgery is so effective at controlling their growth within the CS. 4, 35, 39, 74 These tumors are easily diagnosed on preoperative imaging and aggressive surgery within the CS is rarely indicated. 48, 59, 74 Transcranial approaches to the CS, such as the pterional inter-or extradural approach described by Dolenc 16, 17 and the cranioorbitozygomatic approach, achieve best surgical results with interdural tumors of the lateral sinus wall, due to the existence of a well-defined cleavage plane between the tumor and the parasellar compartment. The surgical outcomes for invasive tumors are less favorable, and tumors originating from the midline have had the highest complication rates. 37, 38, 42, 50, 63, 64 In the analysis of Pamir et al. of transcranial approaches for nonmeningeal tumors of the CS, 29% of patients developed CSF leaks, hematoma, hydrocephalus, diabetes insipidus, cerebral infarction, and additional cranial nerve palsies. 50 Endoscopic access to the parasellar region as an alternative route has become feasible with the development of the extended approaches. 5, 6 There are already several cadaver studies exploring the various techniques of endoscopic endonasal approaches to the CS. 3, 6, 7, 9, 15, 38, 43 Most of the clinical endoscopic experience with tumors involving the CS derives from the removal of pituitary adenomas. 2, 8, 23, 26, 33, 47, 56, 57, 76 Clinical experience with other tumors is limited and publications on endoscopic CS surgery for nonadenomatous, nonmeningeal lesions are sporadic.
Review of the literature (Table 5 ) revealed 7 publications, 10, 27, 29, 33, 45, 56, 68 4 of which focus on endoscopic CS biopsy. 27, 29, 45, 68 One is a case report of endoscope-assisted microsurgery on a CS epidermoid. 10 The other 2 are mixed series that also include pituitary adenomas and meningiomas. 33, 56 Hence, the current report is the largest systematic study on the results of endoscopic endonasal surgery of lesions other than adenomas and meningiomas within the CS to our knowledge to date.
A common factor in selecting patients for endoscopic endonasal surgery was the determination that a transcranial approach would carry significant risk to the cranial nerves and require brain retraction as opposed to a more direct, lower-risk access through an endonasal endoscopic surgical corridor. With the advent of angled endoscopes, it is possible to visualize and access both the medial and lateral aspects of the CS from a purely endonasal endoscopic approach using a medial-to-lateral and anterior-toposterior corridor, with the cranial nerves at the far end of the resection. 14, 24, 60 Debulking of tumors in the CS with opening of the lateral and superior sinus walls and piecemeal removal of the tumor in "safe" locations enables an improvement in cranial nerve function with low risk for new deficit. 21, 22, 28, 57, 77 The overall rate of 66.7% recovery of preexisting cranial neuropathies in this series is in line with previous experience. 77 New cranial nerve deficit due to the procedure was seen in only 1 case and it completely resolved, as there was no structural damage.
The goals of surgery, biopsy versus lesion debulking versus GTR, were carefully discussed prior to the procedure as a part of an overall individual treatment plan based on the eventual use of either single-dose or fractionated radiotherapy. These decisions should ideally be made alongside a radiation oncologist and neurooncologist as part of a multidisciplinary tumor board.
The goal in the metastatic lesions and lymphomas in our series was primarily biopsy with partial debulking to relieve cranial neuropathies. For chordomas and chondrosarcomas a more aggressive surgical strategy is advocated and can be better achieved through the medial endonasal endoscopic approach as these tumors are extradural in origin, are hypovascular, and are typically midline or parasagittal lesions. 24, 25, 30 The pre-and postoperative MRI of a patient with chondrosarcoma is shown in Fig. 3 , which demonstrates GTR within the CS.
Particularly for chordomas, attempts at GTR are critical since the tumors are less sensitive to radiotherapy. 23, 25, 33, 39, 40, 41, 50, 66 Looking specifically at our chordoma cases, there were 4 tumors with CCA encasement between 50% and 100% and GTR could only be achieved in 1 case; 2 patients with resection rates of 80% and 90% had tumor recurrence at 28.6 and 33 months after proton beam radiation therapy. Tumor recurrence was also seen in 1 patient with chondrosarcoma in whom an 85% extent of resection was achieved. In this patient, CCA encasement was 75%, and firm tumor around the carotid structure was left behind. All patients had significant lasting relief of preexisting cranial neuropathies.
Dermoid cysts involving the CS are extremely rare benign lesions and in the few reported cases are described as interdural and extradural tumors usually originating in the lateral wall of the CS. 50, 58, 73 In our case an interdural localized dermoid tumor was suspected radiographically (Fig. 4 left) and a surgical approach was planned accordingly, gaining lateral access additionally via a transmaxillary transpterygoid approach. In the latter approach the vidian nerve is typically mobilized superolaterally to avoid injury. Hypolacrimation, as a possible complication, was not encountered postoperatively. The lesion could be removed and the postoperative MRI (Fig. 4 right) showed no residual tumor or postoperative bleeding.
The patient did, however, develop a transient CN VI nerve palsy associated with Horner's syndrome. Both conditions fully resolved 6 months after surgery. It is known that oculosympathetic nerve fibers leave the internal carotid artery (ICA) and then join the abducens nerve for a short distance in the posterior portion of the CS. 55, 67 We presume that manipulation during surgery had possible transient implications for the function of those fibers, which is consistent with the reversibilty of the deficits.
Cavernous hemangioma of the CS also is another rare lesion located interdurally and frequently displaces the ICA medially and CNs III, IV, and V laterally. 44, 46 Such lesions are highly vascular and an extradural approach with early devascularization of the dural and ICA feeders for hemostatic control is advocated. Piecemeal removal is therefore not possible. 44, 46, 65, 78, 81 We achieved GTR in 2 of our 3 cases although hemostasis was difficult to achieve in the third case. In endoscopic cases previously reported by Jeon at al. and by Cobbs and Wilson the authors intentionally performed a subtotal resection. 11, 31 Once again, given the efficacy of radiosurgery for these lesions, attempts at removal should be weighed against the risks and benefits compared with less invasive treatments.
Intracranial hemangiopericytomas are very rare lesions. 19 Bonde and Goel reported of 2 adult cases located in the CS; GTR was achieved via an extradural temporal approach in both cases, but disease recurred after 3 and 10 years. 4 One hemangiopericytoma in our series was located within the CS and was removed via a transplanar approach. The tumor was firm, resembling a meningioma, and highly vascular. Nevertheless, 80% of the tumor volume within the CS could be removed. The published rates of GTR for hemangiopericytomas in the CNS range from 32% to 67%. Due to small numbers a statistically significant benefit for GTR was never demonstrated.
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Irrespective of the underlying pathology we looked for common factors determinaing the outcome. Our results indicate that CCA encasement over 75% and a KS grade of 3-4 are possible negative predictors for GTR within the CS. This would be consistent with a recent publication that proposed that lateral tumor extension with encasement of vessels may be a potential limitation of GTR. 79 Further studies with larger numbers available for multivariate analysis are needed to statistically confirm this assumption.
The neurological outcomes indicate though that careful debulking can be sufficient to relieve preexisting symptoms and we advocate that GTR should not always be the goal, when tumor control can be achieved with adjuvant therapies.
Conclusions
The results of our series demonstrate that purely endonasal endoscopic approaches can be used to address a variety of nonadenomatous, nonmeningeal pathologies in the CS. Our results indicate that KS grade and degree of carotid encasement could be helpful in predicting the feasible extent of resection within the CS irrespective of the underlying pathology. In some cases GTR should be the goal of surgery while in others a biopsy with adjuvant therapies or debulking to relieve preexisting cranial neuropathies is sufficient. The goals of surgery should be clearly established preoperatively in consultation with radiation and medical oncologists.
